Sodium homeostasis is preserved in a global 11-hydroxysteroid dehydrogenase type 1 knockout mouse model

被引:3
|
作者
Christensen, Thorbjorn H. [1 ,2 ]
Bailey, Matthew A. [1 ]
Kenyon, Christopher J. [1 ]
Jensen, Boye L. [2 ]
Hunter, Robert W. [1 ]
机构
[1] Univ Edinburgh, Univ British Heart Fdn Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland
[2] Univ Southern Denmark, Dept Cardiovasc & Renal Res, Odense, Denmark
关键词
SALT-SENSITIVE HYPERTENSION; METABOLIC SYNDROME; 11-BETA-HYDROXYSTEROID DEHYDROGENASES; GLUCOCORTICOID ACTION; MICE; OBESITY; MODULATION; HYPERGLYCEMIA; RECEPTOR; SGK1;
D O I
10.1113/EP085177
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
New Findings What is the central question of this study? Glucocorticoids act in the kidney to promote salt and water retention. Renal 11-hydroxysteroid dehydrogenase type1 (11HSD1), by increasing local concentrations of glucocorticoids, may exert an antinatriuretic effect. We hypothesized that global deletion of 11HSD1 in the mouse would give rise to a salt-wasting renal phenotype. What is the main finding and its importance? We subjected a mouse model of global 11HSD1 deletion to studies of water and electrolyte balance, renal clearance, urinary steroid excretion, renin-angiotensin system activation and renal sodium transporter expression. We found no significant effects on renal sodium or water excretion. Any effect of renal 11HSD1 on sodium homeostasis is subtle. Glucocorticoids act in the kidney to regulate glomerular haemodynamics and tubular sodium transport; the net effect favours sodium retention. 11-Hydroxysteroid dehydrogenase type1 (11HSD1) is expressed in the renal tubules and the interstitial cells of the medulla, where it is likely to regenerate active glucocorticoids from inert 11-keto forms. The physiological function of renal 11HSD1 is largely unknown. We hypothesized that loss of renal 11HSD1 would result in salt wasting and tested this in a knockout mouse model in which 11HSD1 was deleted in all body tissues. In balance studies, 11HSD1 deletion had no effect on water, sodium or potassium metabolism; transition to a low-sodium diet did not reveal a natriuretic phenotype. Renal clearance studies demonstrated identical haemodynamic parameters (arterial blood pressure, renal blood flow and glomerular filtration rate) in knockout and wild-type mice, but revealed an augmented kaliuretic response to thiazides in 11HSD1 knockout animals. There was no effect on the natriuretic response to the amiloride analogue benzamil. Urinary excretion of deoxycorticosterone was higher in 11HSD1 knockout mice, and there was hypertrophy of cells in the zona fasciculata of the adrenal cortex. There was no difference in the activity of the renin-angiotensin and nitric oxide systems, no difference in renal histology and no difference in the abundance of key tubular transporter proteins. We conclude that any effect of 11HSD1 on renal sodium excretion is subtle.
引用
收藏
页码:1362 / 1378
页数:17
相关论文
共 50 条
  • [21] Monotoring 11β-hydroxysteroid dehydrogenase type 1 levels in mouse liver during caloric restriction
    Loerz, C.
    Maser, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S67 - S67
  • [22] Localization and glucocorticoid regulation of 11β-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain
    Pelletier, G.
    Luu-The, V.
    Li, S.
    Bujold, G.
    Labrie, F.
    NEUROSCIENCE, 2007, 145 (01) : 110 - 115
  • [23] 11β-hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
    Stulnig, TM
    Waldhäusl, W
    DIABETOLOGIA, 2004, 47 (01) : 1 - 11
  • [24] 11β-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
    T. M. Stulnig
    W. Waldhäusl
    Diabetologia, 2004, 47 : 1 - 11
  • [25] A Novel Mechanism Explaining Salt Sensitivity: Post-Transcriptional Regulation of 11-Hydroxysteroid Dehydrogenase Type 2 by Mirna
    Frey, F. J.
    Frey, B.
    Andrieu, T.
    Dick, B.
    Rezaei, M.
    SWISS MEDICAL WEEKLY, 2011, 141 : 4S - 4S
  • [26] Microglia Express Functional 11β-Hydroxysteroid Dehydrogenase Type 1
    Gottfried-Blackmore, Andres
    Sierra, Amanda
    Mcewen, Bruce S.
    Ge, Renshan
    Bulloch, Karen
    GLIA, 2010, 58 (10) : 1257 - 1266
  • [27] Piperidine amides as 11β-hydroxysteroid dehydrogenase type 1 inhibitors
    Flyren, Katarina
    Bergquist, Lars O.
    Castro, Victor M.
    Fotsch, Christopher
    Johansson, Lars
    Jean, David J. St., Jr.
    Sutin, Lori
    Williams, Meredith
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3421 - 3425
  • [28] 11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
    Wake, DJ
    Walker, BR
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 215 (1-2) : 45 - 54
  • [29] Perhydroquinolylbenzamides as novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1
    Coppola, GM
    Kukkola, PJ
    Stanton, JL
    Neubert, AD
    Marcopulos, N
    Bilci, NA
    Wang, H
    Tomaselli, HC
    Tan, J
    Aicher, TD
    Knorr, DC
    Jeng, AY
    Dardik, B
    Chatelain, RE
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) : 6696 - 6712
  • [30] Glucocorticoids, 11β-hydroxysteroid dehydrogenase type 1, and visceral obesity
    Paulmyer-Lacroix, O
    Boullu-Ciocca, S
    Oliver, C
    Dutour, A
    Grino, M
    M S-MEDECINE SCIENCES, 2003, 19 (04): : 473 - 476